Vegetable growers, Dow settle dispute over new herbicide
A coalition of vegetable growers and food producers led by Indiana-based Red Gold Inc. will ease off their opposition to a new herbicide developed by Indianapolis-based Dow AgroSciences LLC.
Life Science & Biotech
Articles
$100M IU neuroscience center set to open
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
Life sciences firm Hologic closing 200-worker Zionsville facility
Massachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville, bringing an end to 200 local jobs.
Cook Medical shelves Midwest expansion plans
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
Life Sciences Power Breakfast – transcript
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation at the July 25 event.
Dow Agro sales surge to record in second quarter
The Indianapolis-based division of Dow Chemical Co. posted record second quarter sales of $1.7 billion, up 12 percent from the year-ago period, due to a small increase in prices and the introduction of new products.
Indiana Blood Center tapping new vein of revenue
Group sees role in cellular therapy as growth area with profit margins higher than core business.
Indiana life sciences companies rethink innovation
Research and development comes under pressure in an age of austerity.
Bioanalytical taps accountant for turnaround
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
Life sciences hold up in recession
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
Biomet gives ortho industry hope
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
House swipes at health law with repeal of medical device tax
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
Orthopedic startups attracting big money
The Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more fuel into a fairly stagnant entrepreneurial sector.
IU research leads to new genetic test
It took the identification of 19 different genes for researchers at the Indiana University School of Medicine to develop a test for a rare form of cancer. But their gene-hunting has paid off, as a Texas-based company announced Monday the test is available for doctors to use.
U.S. losing drug-research jobs to other countries
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
Indiana slips in life sciences funding
Indiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies, according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
Cancer tools help Roche with Alzheimer’s drug
Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.
SCHREIBER: Innovation will drive health care industry
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
BioCrossroads launches second seed fund
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
Zimmer profit up slightly, meets expectations
Indiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit on higher sales in all global regions, particularly the Asia Pacific.